| (Values in U.S. Thousands) | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -520 | -560 | -560 | -640 | -1,340 |
| Net Income Growth | +7.14% | unch | +12.50% | +52.24% | -185.11% |
Hypha Labs Inc. (FUNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Hypha Labs Inc. developed cutting-edge Patent-Pending technology focused on methods of producing the active ingredients found in functional mushrooms such as psilocybin using its patent pending bioreactor design. Hypha Labs Inc., formerly known as Digipath Inc., is based in LAS VEGAS, NV.
Fiscal Year End Date: 09/30